Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

DGAP Post-admission Duties announcement: Fresenius Medical Care AG & Co. KGaA / Fresenius Medical Care AG & Co. KGaA / Announcement pursuant to Art. 5 para. 1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 Fresenius Medical Care AG & Co. KGaA: Release of a capital market information 11.11.2019 / 09:44 Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. - Share buy-back - 21st Interim Report In the period from November 4, 2019 until and including November 8, 2019, a total of 177,000 shares were repurchased within the framework of the share buy-back programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius Medical Care') announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052. The purchase was carried out exclusively by a credit institution commissioned by Fresenius Medical Care via the XETRA trading platform on the Frankfurt Stock Exchange: Day of repurchase Aggregated volume in number of shares Weighted average share price in EUR 04.11.2019 36,000 66.5550 05.11.2019 36,000 67.7284 06.11.2019 35,000 67.7370 07.11.2019 35,000 68.6833 08.11.2019 35,000 68.6178   The total volume of shares repurchased within the framework of this share buy-back in the period from June 17, 2019 until and including November 8, 2019 therefore amounts to 3,903,735 shares. Detailed information on the transactions pursuant to Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care's website at www.freseniusmedicalcare.com under section Investors. Fresenius Medical Care AG & Co. KGaA represented by Fresenius Medical Care Management AG represented by its Management Board Bad Homburg v.d.H., November 11, 2019 11.11.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language:	English
Company:	Fresenius Medical Care AG & Co. KGaA
	Else-Kröner-Straße 1
	61352 Bad Homburg
	Germany
Internet:	www.freseniusmedicalcare.com

End of News	DGAP News Service

909271  11.11.2019